SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action? Rommer PS, Bsteh G, Berger T, Zettl UK, et al. Mult Scler 2021 Aug 13:13524585211039128. doi: 10.1177/13524585211039128.

Read + Share

Amedeo Smart

Independent Medical Education

Rommer PS, Bsteh G, Berger T, Zettl UK, et al. SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action? Mult Scler 2021 Aug 13:13524585211039128. doi: 10.1177/13524585211039128.
PMID: 34387536